Citation 2021

HARINANTENAINA,L: ASAKAWA,Y: DE CLERCQ, E:. (2007). CINNAMACRINS A-C, CINNAFRAGRIN D, AND CYTOSTATIC METABOLITES WITH A-GLUCOSIDASE INHIBITORY ACTIVITY FROM CINNAMOSMA MACROCARPA.. 70(2)

Citation Details

Title	CINNAMACRINS A-C, CINNAFRAGRIN D, AND CYTOSTATIC METABOLITES WITH A-GLUCOSIDASE INHIBITORY ACTIVITY FROM CINNAMOSMA MACROCARPA.
Authors	HARINANTENAINA,L: ASAKAWA,Y: DE CLERCQ, E:
Year	2007
Volume	70
Issue	2

Summary

Year: 2007

Journal: Unknown

Organisms and Their Experiments (1)

Cinnamosma macrocarpa (CANELLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CAPSICODENDRIN	None
3	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPSICODENDRIN	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAPSICODENDRIN	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAPSICODENDRIN	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAPSICODENDRIN	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAPSICODENDRIN	INACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAPSICODENDRIN	INACTIVE
9	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAPSICODENDRIN	INACTIVE
10	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAPSICODENDRIN	INACTIVE
11	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAPSICODENDRIN	INACTIVE
12	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAPSICODENDRIN	INACTIVE
13	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAPSICODENDRIN	INACTIVE
14	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAPSICODENDRIN	INACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CINNAMODIAL	None
16	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CINNAMODIAL	ACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	ACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	ACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	INACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	INACTIVE
22	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	INACTIVE
23	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	INACTIVE
24	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	INACTIVE
25	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	INACTIVE
26	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	INACTIVE
27	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CINNAMODIAL	INACTIVE
28	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CINNAFRAGIN A	None
29	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CINNAFRAGIN ACINNAFRAGIN BCINNAFRAGIN CCINNAFRAGIN DBEMADLENOLIDECINNAMOLIDEPOLYGODIAL,ISO:	INACTIVE
30	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CINNAFRAGIN B	None
31	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CINNAFRAGIN C	None
32	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CINNAFRAGIN D	None
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BEMADLENOLIDE	None
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CINNAMOLIDE	None
35	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	POLYGODIAL,ISO:	None
36	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CINNAFRAGIN B	None

Citation 2021

Citation Details

Summary

Organisms and Their Experiments (1)

Cinnamosma macrocarpa (CANELLACEAE)

Show SPARQL Queries (1)

Query 1